子宫内膜癌雄激素受体CAG重复多态性功能分析及其预后价值评估Evaluation of prognostic significance and functional analysis of androgen receptor CAG repeat polymorphism in endometrial cancer <
子宫内膜癌雄激素受体CAG重复多态性功能分析及其预后价值评估
Evaluation of prognostic significance and functional analysis of androgen receptor CAG repeat polymorphism in endometrial cancer
Introduction: Endometrial cancer (EC) is one of the most common gynecologic cancers in the world, and is a steroid hormone-related disease. Both epidemiologic and clinical studies have suggested that androgen and its intracellular receptor, androgen receptor (AR), are involved in EC. AR gene contains a CAG repeat (encoding for polyglutamine), highly polymorphic in length, that influences its transactivation function. A lineal increase in CAG repeat length is associated with a progressive decrease in AR activity.
Methods: We have genotyped CAG polymorphisms of the AR gene in genomic DNA from a series of 72 consecutive patients with EC, and analyzed the results with regard to the characteristics and clinical outcome of patients. We categorized the CAG repeat lengths into 4 groups according to the quartile in our series, < 20, 20-21, 22-23, and >23.
Results: Our preliminary data found that shorter AR CAG repeat length is associated with poor disease-free survival and overall survival in EC patients. Cox regression also showed that patients with a shorter AR CAG repeat length had a shorter time to progression and worse overall survival when analyzed in the quartile or in the per unit increase of repeat number (hazard ratios (HR) 0.85, 95% confidence interval (CI) 0.76-0.96, P-trend = 0.006 for DFS; HR 0.82, 95% CI 0.73-0.93, P-trend < 0.001 for OS ;).
Conclusion: This study will not only discover prognostic biomarkers to improve the prediction of EC prognosis, but also help us understand the etiology of EC progression.
更多精彩内容,请点击专题报道:http://zt.cmt.com.cn/zt/igcs2012/index.html
copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号